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The detailed description of the distribution of endocrine cells G and D producing
important hormones that regulate activation of other cells in the human stomach
may be a valuable source of information for opinions about mucosa changes in
different diseases of the alimentary tract. The density and distribution of immu-
noreactive G and D cells in the pylorus of humans (donors of organs) were evaluat-
ed. The pylorus samples were collected after other organs were harvested for
transplantation. The number of G cells in the pyloric mucosa of healthy people
was higher than the number of D cells. G and D cells were distributed between
columnar cells of epithelium mucosa. Multiform endocrine cells generally occurred:
gastrin in the middle third of the mucosa and somatostatin cells in the basal half of
the pyloric mucosa. The investigation of the pyloric part of the healthy human
stomach showed a characteristic distribution of cells that reacted with antisera
against gastrin and somatostatin. (Folia Morphol 2012; 71, 1: 39–44)
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INTRODUCTION
Gastrointestinal hormones are secreted by endocrine
cells, which are distributed throughout the mucosa of
the gastrointestinal tract. Endocrine cells play an im-
portant regulatory role in the gastrointestinal tract.
Gastrin, somatostatin, and other gastrointestinal
hormones regulate the functions of the gastrointesti-
nal tract such as secretion of intestinal and fundic
glands, and nutrient and drug absorption [17, 20].
The secretion of hydrochloric acid is an important
function of the human stomach. Gastric acid aids
protein digestion, facilitates the absorption of iron,
calcium, and vitamin B12, and prevents bacterial over-
growth [7, 17]. In humans, acid is continuously se-
creted by parietal cells of gastric mucosa and is pre-
cisely regulated by a variety of neurocrine, paracrine,
and endocrine signals in order to achieve the correct
amount of acid secretion required by the specific situ-
ation [12, 19]. Too much acid can lead to peptic
ulcer disease, gastroesophageal reflux disease, and
stress-related erosion/ulcer disease. Too little acid can
interfere with the absorption of certain nutrients, pre-
dispose to enteric infection, and interfere with the
absorption of some medications [17]
Important regulators of gastric acid secretion are
gastrin G cells and somatostatin D cells. Gastrin, the
main stimulant of acid secretion during meal inges-
tion, is produced in G cells of the gastric antrum and
duodenal mucosa, but the major source of serum
gastrin is antral G cells [19, 24]. The pyloric gland
area, the hallmark of which is the gastrin or G cell,
comprises 20% of the antrum [5]. The pyloric gland
also contains D cells, which produce somatostatin.
Somatostatin is the main inhibitor of basal gastric
acid secretion. The regulation of gastric acid secretin
is achieved by the interplay between two major gas-
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tric endocrine cells: the gastrin G cell and the soma-
tostatin D cell. Each of these agents acts directly on
the parietal cell as well as indirectly by modulating
the secretion of neuroendocrine cells [19].
Gastrin indirectly stimulates acid secretion
through induction of histamine release from entero-
chromaffin-like (ECL) cells. Histamine subsequently
stimulates gastric acid secretion through H2 recep-
tors on parietal cells [3, 18, 29]. Increased acid le-
vels then stimulate putative chemoreceptors on py-
loric D cells to secrete somatostatin and block fur-
ther release of gastrin and gastric acid. Thus gastric
acid secretion is regulated by a negative feedback
mechanism involving somatostatin [6, 18].
The alterations in the relative numbers of gas-
trin G cells and somatostatin D cells may play a key
role in gastroduodenal disease.
Due to the difficulties in obtaining human sam-
ples our current level of knowledge concerning the
DNES cells is founded on the results of research con-
ducted on animals.
The limited data available regarding the descrip-
tion of the endocrine cells of the human gastrointes-
tinal tract is based on a restricted number of sam-
ples collected during surgical procedures or biop-
sies. In the present paper, the authors investigated
the distribution, morphology, and number of G cells
and D cells in the healthy human pyloric gastric
mucosa, in order to provide basic materials for study-
ing gastrointestinal endocrinology, gastroenterolo-
gy, and prevention of disease in the digestive sys-
tem, and its treatment.
MATERIAL AND METHODS
Nineteen donors of organs with normal gastric
mucosa were used in the study. There were 10 men
with mean age 43.9 years, range from 21 to 65 years,
with mean body weight 83.25 kg and 9 women with
mean age 46.3 years; range from 19 to 58 years
with mean body weight 66.33 kg.
Each patient was treated in the Intensive Care
Unit due to brain damage caused by brain injury or
by cerebral haemorrhage, and only in a few cases
was the brain damage secondary in origin due to
primary cardiac arrest. Patients were artificially ven-
tilated and received circulatory support and
parenteral and enteral nutrition. No one received
steroids.
Each patient presenting clinical symptoms of
brain death was considered as an organ donor. The
irreversible brain damage was confirmed by special
clinical examination and with angiography (no blood
flow within the brain arteries).
After brain death was diagnosed and the indi-
vidual’s death was recognized by the Committee,
organ samples of about 1 cm2 were taken from each
body (from the same part of the pylorus) after the
other organs (kidneys, liver, heart) were harvested
for transplantation.
Ethical issues
The study protocol was approved by the Ethics
Committee of the Medical University of Białystok
(R-I-002/345/2007), and written informed consent was
obtained from each participant or from members
of the patient’s family.
The tissues were immediately fixed in Bouin’s
solution and routinely embedded in paraffin. The
stomach sections were cut perpendicular to the
mucosal surface and included the entire depth of
the mucosa. Specimens were stained with haema-
toxylin and eosin (H+E) for general histological
examination, and processed for immunohistochem-
istry for the detection of gastrin and somatostatin.
Light microscopic immunohistochemistry
Procedure. The paraffin blocks were cut into
4-mm sections (3 sections from each subject) and at-
tached to positively charged glass slides.
Immunohistochemistry was performed using an
EnVision Plus-HRP Detection Kit (Dako; Glostrup,
Denmark) [4]. Immunostaining was performed us-
ing the following protocol. Paraffin-embedded sec-
tions were deparaffinised and hydrated in alcohols.
For antigen retrieval, the sections were subjected to
pretreatment in a pressure chamber heating for
1 min at 21 psi (one pound force per square inch
[1 psi] equates to 6.895 kPa, conversion factor provid-
ed by United Kingdom National Physical Laborato-
ry) at 125°C using Target Retrieval Solution Citrate
pH 6.0 S 2369 (Dako; Glostrup, Denmark). After
being cooled to room temperature, sections were
incubated with Peroxidase Blocking Reagent S 2001
(Dako; Glostrup, Denmark) for 10 minutes to block
endogenous peroxidase activity.
The sections were incubated overnight at 4°C in
a humidified chamber with the diluted polyclonal
rabbit: anti-gastrin (1:800, A 0568 Dako; Glostrup,
Denmark), and anti-somatostatin human antiserum
(1:20 000; H-031-30 Phoenix Pharmaceutical Inc.),
followed by incubation with secondary antibody
(conjugated to horseradish peroxidase-labelled poly-
mer). Bound antibodies were visualized by 1-min
incubation with liquid 3,3’-diaminobenzidine sub-
strate chromogen. The sections were finally coun-
terstained in Vector QS haematoxylin, mounted, and
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evaluated under light microscope. Appropriate
washing with Wash Buffer S 3006 (Dako; Glostrup,
Denmark) was performed between each step.
The specificity tests performed for the gastrin and
somatostatin antibody included: negative control,
where the antibodies were replaced by normal rab-
bit serum (Vector Laboratories; Burlingame, CA) at
the respective dilution, and positive control was
done for specific tissue recommended by producer.
Quantitative analysis
Immunopositive cells were counted in 5 visual
fields in one section, each field being 0.785 mm2, at
a magnification of 200¥ (20¥ the lens and 10¥ the
eyepiece). Three specimens in each of the 19 sub-
jects were analysed.
The analysis of the preparations and their pho-
tographic documentation were performed with an
Olympus B¥50 light microscope with a video cir-
cuit and a Pentium 120 PC computer with NIS Ele-
ments AR 3.10 NIKON software for microscope im-
age analysis.
The cell count was expressed as the mean num-
ber of G and D cells per visual field.
Statistical analysis
All the presented data were statistically analy-
sed by means of the software package Statistica
Version 7.0. Descriptive statistics (mean, SD) were
calculated for age, weight, and gastrin-positive and
somatostatin-positive cell numbers. Results were
expressed as mean ± SD.
RESULTS
Light microscopic immunohistochemistry
Immunoreactive endocrine cells for gastrin and
somatostatin were identified in the pylorus of the
healthy human in this study.
There was no immunoreactivity when the primary
antibodies were omitted from the staining proce-
dure.
Pyloric endocrine cells were characterised on the
basis of cytoplasmic staining. All the immunoreac-
tive (IR) cells showed a dark brown colour, and in
the cell body and cytoplasmic processes, the secre-
tory granules were seen. The shape of IR endocrine
cells was distinctive and variform, and quite differ-
ent from the epithelial cells. The nuclei were located
in the middle part of cell body, and showed a spheri-
cal shape.
Gastrin and somatostatin cells were distributed
between columnar cells of gastric epithelium.
The gastrin antiserum visualised a large number
of endocrine cells in the pyloric mucosa (mean value
83.6 cells per visual field). Generally, they occurred
in the middle third of the mucosa with few in the
basal or upper part. Some of the cells were round-
ed; others were elongated or irregular in shape. The
most of the gastrin positive cells appeared as closed
type, without a lumen contact, but some of the cells
seemed to reach the lumen. Staining intensity of gas-
trin was strong, but in some gastrin positive cells it
was moderate (Fig. 1).
The D cells were identified by means of an anti-
serum to somatostatin. The somatostatin-immu-
noreactive cells usually had long slender processes
and were less numerous (mean value 31.8 cells per
visual field) than gastrin-immunoreactive cells; they
were exclusively dispersed in the basal half of the
mucosa although scattered cells occurred higher up
in the mucosa. Somatostatin-positive cells distri-
buted between gastrointestinal columnar epitheli-
um mainly displayed strong staining of somatosta-
Figure 1A, B. Photomicrographs illustrating the distribution of
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tin. The shape of the cells was irregular, pyramidal,
round, or elongated. The apical cytoplasmic process-
es extended to the stomach lumen, and basal pro-
cesses extended to the basement membrane or to
the neighbouring epithelial cells (Fig. 2).
DISCUSSION
It is well known that regulation of the motility, se-
cretion, and absorption of the alimentary tract is co-
ordinated by neural and hormonal controls [9, 18].
Gastrin is the first peptide to be described and has
been localized to specific endocrine-type cells called
G cells [22]. Some hormones and neurotransmitters sti-
mulate the release of gastrin, while others, such as
somatostatin, inhibit release [27]. Since gastrin was
identified, many studies about it and other endocrine-
like type cells have been published. Most studies were
physiological studies using animals [22, 24, 25]. How-
ever, a few focused on the expression of endocrine
cells in human gastric mucosa [12, 23, 24, 28].
In the present study, we demonstrated the oc-
currence and distribution patterns of gastrin- and
somatostatin-immunoreactive cells in human pyloric.
Recently, Liu et al. [12] demonstrated gastrin and
somatostatin immunostaining in the gastric antral
biopsies from patients with dyspeptic complaints.
Our findings agree with the distribution patterns
reported in these results, but we detected larger
number of G and D cells in the pyloric part of the
human stomach. These differences might be due to
different antisera, methods, and species used in each
study. But until now, no report has shown the num-
bers of endocrine cells in healthy human gastrointes-
tinal tract in such large samples.
The distribution of G and D cells within the hu-
man pyloric mucosa and their shape generally agree
with the results reported by us in rat stomach [8].
The number of gastrin- and somatostatin-contain-
ing cells in the pyloric part of the rat stomach was
lower than in the human stomach [8].
The distribution, density, and location of vari-
ous endocrine cells have some relation to their func-
tion. The major endocrine function of gastric pyloric
antrum is the secretion of gastrin. Gastrin is pro-
duced by G cells in the antral and duodenal mu-
cosa, but the main source of gastrin is the antral
G cells. The main inhibitor of antral G-cells is intralu-
minal acid, acting via release of somatostatin from
antral D-cells [16, 26]. These cells are functionally
and anatomically closely connected to the G cells.
In this study, we found that the numerous so-
matostatin-positive cells have long, immunoreactive
basal processes.
The current hypothesis suggests that the release
of somatostatin from multiple sites along the pro-
cess allows a single cell to affect several neighbour-
ing cells at the same time.
D-cells have been shown in close contact with
neighbouring antral G-cells by long cytoplasmic pro-
cesses, suggesting the regulatory potency on gas-
trin-containing cell function [1]. Somatostatin inhib-
its gastrin secretion and also decreases gastrin mRNA
levels by affecting both gastrin gene transcription
and mRNA stability [11]. Much data support the
hypothesis that somatostatin represents a physio-
logical paracrine regulator of gastrin cell function.
Neuroendocrine cells maintain balance in the epi-
thelium of the gastrointestinal tract, reacting to me-
chanical events and chemical changes that occur in
their direct environment [14]. Normally, gastrin release
is suppressed when the luminal antral pH falls below
3. In addition, there is an inhibitory control exerted on
gastrin release by cholecystokinin. The inhibition of
gastrin release exerted by both gastric acid and chole-
cystokinin is mediated mainly via the release of soma-
tostatin by D cells within the antral mucosa [12]. An
Figure 2A, B. Somatostatin-immunoreactive cells in the human
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increase in pH, intake of food, increase of pressure in
the stomach, or excitation introduced by the vagus
nerve or mucosa nerve plexus could make G cells se-
crete more gastrin. A decrease in pH stimulated by
somatostatin or other gastrointestinal hormones, and
excitation of the sympathetic nerve, could inhibit the
secretion of gastrin [21, 27, 28].
Gastrin has a unique regional regulatory effect
on the secretion of somatostatin in the stomach [21].
Somatostatin widely exists in the gastrointesti-
nal tract, with its highest concentration in the gas-
tric pylorus area. There are two major molecular
forms of somatostatin: somatostatin 14 (1.6 K) and
somatostatin 28 (3.5 K), both being present in the
gastrointestinal tract [25].
In the stomach, somatostatin cells are closely
coupled to their target cells (e.g. parietal, ECL, and
gastrin cells) either directly via cytoplasmic process-
es or indirectly via the local circulation [19].
Gastrin G and somatostatin D cells are endocrine
cells closely related to the function of the gastrointes-
tinal system. Several studies have now demonstrat-
ed both D cell mass and somatostatin secretion were
markedly reduced in Helicobacter pylori infected
patients, whereas the density of G cells and gastrin
levels were elevated [12, 13]. These data suggest an
intricate balance among immune factors and stom-
ach neuropeptides, including somatostatin and gas-
trin, in the control of gastrointestinal function.
Alterations in relative numbers of G and D cells
and their secretion often affects the normal func-
tions of the digestive tract, even causing clinical
symptoms or syndromes.
Circulating native somatostatin has a short half-
-life. Long-acting analogues like the decapeptide oc-
treotide have been developed and somatostatin
analogues have been used to treat intractable diar-
rhoea, bleeding from oesophageal varices in portal
hypertension, dumping syndrome, and gastrointes-
tinal fistulae [10]. Numerous clinical disorders, in
addition to neuroendocrine tumours and variceal
bleeding, have been treated with long-acting soma-
tostatin analogues, although in many instances there
is a lack of prospective, randomized controlled tri-
als [13]. Several lines of evidence have suggested
a possible therapeutic benefit from long-acting soma-
tostatin analogues in the treatment of inoperable
hepatocellular carcinoma [15]. There has been long-
-standing interest in the possible therapeutic use of
somatostatin or its analogues in the management
of obesity and one of its major complications, type 2
diabetes mellitus [2]. The results of these clinical
trials should stimulate further studies.
In order to obtain a better understanding of the
functional role of gastrin and somatostatin, we in-
vestigated their immunocytochemical identifica-
tion, localisation, and number in the pyloric part
of the human stomach. Hopefully, the knowledge,
acquired throughout the reported study, may lead
to an identification of other, still unknown, roles
of gastrin and somatostatin in physiological and
pathological conditions.
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